Home

Operator Skeptisch Sockel Pulls merck Folge Sichern Nachlässigkeit

Merck says experimental Covid pill cuts risk of death, hospitalization by  50 percent
Merck says experimental Covid pill cuts risk of death, hospitalization by 50 percent

Merck pulls close to Pfizer in next-gen pneumococcal vaccine race as FDA  fast-tracks 15-strain vaccine | Fierce Pharma
Merck pulls close to Pfizer in next-gen pneumococcal vaccine race as FDA fast-tracks 15-strain vaccine | Fierce Pharma

Vioxx Drug Pulled from Shelves : NPR
Vioxx Drug Pulled from Shelves : NPR

HCPC Announces 2016 Compliance Packages of the Year | Healthcare Packaging
HCPC Announces 2016 Compliance Packages of the Year | Healthcare Packaging

Merck's COVID-19 antiviral pill is now approved in the U.K. : Coronavirus  Updates : NPR
Merck's COVID-19 antiviral pill is now approved in the U.K. : Coronavirus Updates : NPR

Merck pulls out of license deal with Ono Pharma for MS drug ceralifimo
Merck pulls out of license deal with Ono Pharma for MS drug ceralifimo

Merck pulls Keytruda's FDA nod for third-line stomach cancer | pharmaphorum
Merck pulls Keytruda's FDA nod for third-line stomach cancer | pharmaphorum

Merck's Keytruda Pulled for SCLC as FDA Re-Evaluates Past Accelerated  Approvals | BioSpace
Merck's Keytruda Pulled for SCLC as FDA Re-Evaluates Past Accelerated Approvals | BioSpace

Merck's (MRK) Covid Drug Linked to Viable, Spreading Mutants, Study Says -  Bloomberg
Merck's (MRK) Covid Drug Linked to Viable, Spreading Mutants, Study Says - Bloomberg

Gardasil pulls in $1.5bn, driving vaccines for Merck - BioProcess  InsiderBioProcess International
Gardasil pulls in $1.5bn, driving vaccines for Merck - BioProcess InsiderBioProcess International

Could a popular COVID-19 antiviral supercharge the pandemic? | Science |  AAAS
Could a popular COVID-19 antiviral supercharge the pandemic? | Science | AAAS

Merck leads rivals in novel drug approvals | Evaluate
Merck leads rivals in novel drug approvals | Evaluate

Merck (MRK) Molnupiravir Pill Could Change the Fight Against Covid -  Bloomberg
Merck (MRK) Molnupiravir Pill Could Change the Fight Against Covid - Bloomberg

FDA authorizes Merck's Covid-19 pill, but stresses its use should be limited
FDA authorizes Merck's Covid-19 pill, but stresses its use should be limited

Fresenius pulls off sterile injectables double whammy, snags Akorn as well  as Merck KGaA's biosimilars business | Fierce Pharma
Fresenius pulls off sterile injectables double whammy, snags Akorn as well as Merck KGaA's biosimilars business | Fierce Pharma

Merck-Pulls-Plug-Painkiller-Vioxx
Merck-Pulls-Plug-Painkiller-Vioxx

Merck & Co pulls out of hepatitis C R&D as market shrinks - PMLiVE
Merck & Co pulls out of hepatitis C R&D as market shrinks - PMLiVE

Merck & Co - Drug Company History, Products & Lawsuits
Merck & Co - Drug Company History, Products & Lawsuits

Merck Pulls Keytruda for SCLC | LCFA
Merck Pulls Keytruda for SCLC | LCFA

Merck-Launches-Alzheimers-Trial
Merck-Launches-Alzheimers-Trial